Kyla A. McKay

2.3k total citations
54 papers, 1.5k citations indexed

About

Kyla A. McKay is a scholar working on Pathology and Forensic Medicine, Neurology and Psychiatry and Mental health. According to data from OpenAlex, Kyla A. McKay has authored 54 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Pathology and Forensic Medicine, 12 papers in Neurology and 9 papers in Psychiatry and Mental health. Recurrent topics in Kyla A. McKay's work include Multiple Sclerosis Research Studies (47 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (8 papers) and Polyomavirus and related diseases (7 papers). Kyla A. McKay is often cited by papers focused on Multiple Sclerosis Research Studies (47 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (8 papers) and Polyomavirus and related diseases (7 papers). Kyla A. McKay collaborates with scholars based in Sweden, Canada and United States. Kyla A. McKay's co-authors include Helen Tremlett, Jan Hillert, John D. Fisk, Scott B. Patten, Ruth Ann Marrie, Ali Manouchehrinia, Lindsay Berrigan, Sharon Warren, Christina Wolfson and Kirsten M. Fiest and has published in prestigious journals such as Neurology, Annals of Neurology and Scientific Reports.

In The Last Decade

Kyla A. McKay

52 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kyla A. McKay Sweden 21 1.2k 287 214 192 146 54 1.5k
Virender Bhan Canada 19 1.1k 1.0× 374 1.3× 252 1.2× 259 1.3× 142 1.0× 40 1.6k
Lorena Lorefice Italy 23 956 0.8× 250 0.9× 183 0.9× 217 1.1× 196 1.3× 102 1.5k
Naila Makhani United States 16 859 0.7× 264 0.9× 105 0.5× 170 0.9× 139 1.0× 30 1.2k
Laura De Giglio Italy 22 920 0.8× 261 0.9× 166 0.8× 158 0.8× 144 1.0× 56 1.3k
Giuseppe Fenu Italy 23 1.0k 0.9× 341 1.2× 168 0.8× 218 1.1× 226 1.5× 92 1.5k
Laurie Wagner United States 15 777 0.7× 313 1.1× 162 0.8× 103 0.5× 104 0.7× 32 1.4k
María José Sá Portugal 19 985 0.8× 297 1.0× 134 0.6× 162 0.8× 110 0.8× 99 1.4k
Edgardo Cristiano Argentina 23 1.1k 0.9× 486 1.7× 226 1.1× 278 1.4× 147 1.0× 116 1.7k
Nadia Reider Canada 10 921 0.8× 242 0.8× 182 0.9× 182 0.9× 120 0.8× 11 1.2k
Maria Milazzo United States 14 814 0.7× 230 0.8× 131 0.6× 119 0.6× 81 0.6× 22 1.0k

Countries citing papers authored by Kyla A. McKay

Since Specialization
Citations

This map shows the geographic impact of Kyla A. McKay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyla A. McKay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyla A. McKay more than expected).

Fields of papers citing papers by Kyla A. McKay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kyla A. McKay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyla A. McKay. The network helps show where Kyla A. McKay may publish in the future.

Co-authorship network of co-authors of Kyla A. McKay

This figure shows the co-authorship network connecting the top 25 collaborators of Kyla A. McKay. A scholar is included among the top collaborators of Kyla A. McKay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kyla A. McKay. Kyla A. McKay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Manouchehrinia, Ali, Jan Hillert, Kyla A. McKay, et al.. (2025). Prodromal phase of multiple sclerosis: evidence from sickness absence patterns before disease onset – a matched cohort study. Journal of Neurology Neurosurgery & Psychiatry. 96(10). 960–965. 1 indexed citations
2.
Tremlett, Helen, Feng Zhu, Karl Everett, et al.. (2025). Healthcare use is elevated two decades before a first demyelinating event and differs by age and sex. Annals of Clinical and Translational Neurology. 12(2). 415–432. 4 indexed citations
3.
Marrie, Ruth Ann, James M. Bolton, Çharles N. Bernstein, et al.. (2025). Peripartum Mental Illness in Mothers With Multiple Sclerosis and Other Chronic Diseases in Ontario, Canada. Neurology. 104(4). e210170–e210170. 1 indexed citations
4.
Tremlett, Helen, Karl Everett, Colleen J. Maxwell, et al.. (2025). Phenotyping Healthcare Use 2–3 Decades Before the First Multiple Sclerosis Demyelinating Event. Annals of Clinical and Translational Neurology. 12(8). 1585–1594.
5.
McKay, Kyla A., et al.. (2024). Disclosing or concealing multiple sclerosis in the workplace: two sides of the same coin—insights from a Swedish population-based survey. Frontiers in Public Health. 12. 1331746–1331746. 3 indexed citations
6.
Tremlett, Helen, Ruth Ann Marrie, Lisa M. Lix, et al.. (2024). Comorbidities and their association with outcomes in the multiple sclerosis population: A rapid review. Multiple Sclerosis and Related Disorders. 92. 105943–105943. 3 indexed citations
7.
Tremlett, Helen, Katharina Fink, Ruth Ann Marrie, et al.. (2024). Incidence rate and prevalence of pediatric‐onset multiple sclerosis in Sweden: A population‐based register study. European Journal of Neurology. 31(5). e16253–e16253. 3 indexed citations
8.
Marrie, Ruth Ann, Ping Li, Kyla A. McKay, et al.. (2023). Incidence and prevalence of paediatric-onset multiple sclerosis in two Canadian provinces: a population-based study representing over half of Canada’s population. Journal of Neurology Neurosurgery & Psychiatry. 95(3). 229–234. 7 indexed citations
9.
Kowalec, Kaarina, Kathryn C. Fitzgerald, Amber Salter, et al.. (2023). Polygenicity of Comorbid Depression in Multiple Sclerosis. Neurology. 101(5). e522–e532. 6 indexed citations
10.
Hossin, Muhammad Zakir, Lorena Fernández de la Cruz, Kyla A. McKay, et al.. (2023). Association of pre-existing maternal cardiovascular diseases with neurodevelopmental disorders in offspring: a cohort study in Sweden and British Columbia, Canada. International Journal of Epidemiology. 53(1). 4 indexed citations
11.
Stawiarz, Leszek, Kyla A. McKay, Benjamin Victor Ineichen, et al.. (2022). Association between brain volume and disability over time in multiple sclerosis. Multiple Sclerosis Journal - Experimental Translational and Clinical. 8(4). 3090507430–3090507430. 5 indexed citations
12.
Cui, Can, et al.. (2022). Medication use and risk of amyotrophic lateral sclerosis—a systematic review. BMC Medicine. 20(1). 251–251. 6 indexed citations
13.
McKay, Kyla A., et al.. (2020). Military service and related risk factors for amyotrophic lateral sclerosis. Acta Neurologica Scandinavica. 143(1). 39–50. 25 indexed citations
14.
Razaz, Neda, Fredrik Piehl, Thomas Frisell, et al.. (2020). Disease activity in pregnancy and postpartum in women with MS who suspended rituximab and natalizumab. Neurology Neuroimmunology & Neuroinflammation. 7(6). 22 indexed citations
15.
McKay, Kyla A., Jan Hillert, & Ali Manouchehrinia. (2019). Long-term disability progression of pediatric-onset multiple sclerosis. Neurology. 92(24). e2764–e2773. 75 indexed citations
16.
McKay, Kyla A., Ruth Ann Marrie, John D. Fisk, Scott B. Patten, & Helen Tremlett. (2018). Comorbidities Are Associated with Altered Health Services Use in Multiple Sclerosis: A Prospective Cohort Study. Neuroepidemiology. 51(1-2). 1–10. 19 indexed citations
17.
McKay, Kyla A., et al.. (2017). Drug exposure and the risk of multiple sclerosis: A systematic review. Pharmacoepidemiology and Drug Safety. 27(2). 133–139. 7 indexed citations
18.
McKay, Kyla A., Charity Evans, John D. Fisk, et al.. (2017). Disease-Modifying Therapies and Adherence in Multiple Sclerosis: Comparing Patient Self-Report with Pharmacy Records. Neuroepidemiology. 48(3-4). 124–130. 6 indexed citations
19.
Little, Julian, Caroline Barakat, Rosemary Martino, et al.. (2016). Genetic variation associated with the occurrence and progression of neurological disorders. NeuroToxicology. 61. 243–264. 15 indexed citations
20.
Zhornitsky, Simon, Kyla A. McKay, Luanne M. Metz, Charlotte E. Teunissen, & Manu Rangachari. (2015). Cholesterol and markers of cholesterol turnover in multiple sclerosis: relationship with disease outcomes. Multiple Sclerosis and Related Disorders. 5. 53–65. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Virender Bhan Breakdown of academic impact, for papers by Lorena Lorefice Breakdown of academic impact, for papers by Naila Makhani Breakdown of academic impact, for papers by Laura De Giglio Breakdown of academic impact, for papers by Giuseppe Fenu Breakdown of academic impact, for papers by Laurie Wagner Breakdown of academic impact, for papers by María José Sá Breakdown of academic impact, for papers by Edgardo Cristiano Breakdown of academic impact, for papers by Nadia Reider Breakdown of academic impact, for papers by Maria Milazzo
Rankless by CCL
2026